Abstrakti
Introduction: In cross-country skiing, the repetitive ventilation of large amounts of cold and dry air strains the airways. The aim of this systematic review was to establish an overview of the current literature on asthma in cross-country skiers, biathletes and ski-orienteers. Methods: Six databases were searched on August 29, 2019. The search yielded 2161 articles. Thirty articles fulfilled the search criteria and were pooled together for a qualitative synthesis. Eight articles were included in the meta-analysis on the prevalence of asthma and the use of asthma medication. Results: According to the meta-analysis, the prevalence of self-reported physician-diagnosed asthma in skiers was 21% (95% CI 14–28%). The onset age of asthma was higher in skiers than in non-skiers with asthma. The prevalence of asthma medication use was on average 23% (CI 95% 19–26%). Several studies reported that asthma was underdiagnosed in skiers, as previously healthy skiers without a prior asthma diagnosis or medication use were frequently found to fulfill diagnostic criteria for asthma according to lung function tests. Studies using bronchial biopsy demonstrated that eosinophilic asthma is not detected in skiers with asthma as often as it is in non-skiers with asthma and that there are signs of airway inflammation even in non-asthmatic skiers. Conclusion: Our findings suggest that the accuracy and coverage of diagnosing asthma in skiers has improved over the recent decades. However, the optimal treatment and natural course of asthma in this population remain unclear. Future research should investigate how the intensity of training, airway infections and their treatment affect the development of asthma among skiers. PRD registration number: CRD42017070940.
| Alkuperäiskieli | Englanti |
|---|---|
| Sivut | 1963-1981 |
| Sivumäärä | 19 |
| Julkaisu | Sports Medicine |
| Vuosikerta | 50 |
| Numero | 11 |
| DOI - pysyväislinkit | |
| Tila | Julkaistu - marrask. 2020 |
| OKM-julkaisutyyppi | A2 Katsausartikkeli tieteellisessä aikakauslehdessä |
Rahoitus
The study was supported by the Tampere Tuberculosis Foundation. Mr Mäki-Heikkilä declares receiving financial support from Tampere Tuberculosis Foundation and Tampere University to author this publication. Dr Karjalainen declares receiving grant from Tampere Tuberculosis Foundation, fees for consulting from Boehringer Ingelheim, Finnish Center for Integrity in Sports, GlaxoSmithKline, Merck Sharp & Dohme, Novartis and Teva and payments for lectures from ALK, AstraZeneca, Chiesi, Boehringer Ingelheim, GlaxoSmithKline, Leo Pharma, Mundipharma, Novartis and Orion Pharma. Dr Parkkari declares no conflicts of interest. Dr Valtonen declares employment for acting as team doctor for Finnish Ski Association via KIHU – Research Institute for Olympic Sports. Dr Lehtimäki declares having received fees for consulting from ALK, AstraZeneca, Boehringer Ingelheim, Chiesi, GSK, Orion Pharma, Mundipharma, Novartis, SanofiGenzyme and Teva, and payments for lectures from AstraZeneca, Boehringer Ingelheim, Chiesi, Circassia, GSK, Orion Pharma, Mundipharma, Novartis, SanofiGenzyme and Teva.
Julkaisufoorumi-taso
- Jufo-taso 2
!!ASJC Scopus subject areas
- Orthopedics and Sports Medicine
- Physical Therapy, Sports Therapy and Rehabilitation
Sormenjälki
Sukella tutkimusaiheisiin 'Asthma in Competitive Cross-Country Skiers: A Systematic Review and Meta-analysis'. Ne muodostavat yhdessä ainutlaatuisen sormenjäljen.Siteeraa tätä
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver